Cellini, Numa
 Distribuzione geografica
Continente #
EU - Europa 3.921
NA - Nord America 2.678
AS - Asia 1.008
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 5
OC - Oceania 4
Totale 7.645
Nazione #
US - Stati Uniti d'America 2.664
DE - Germania 2.174
SE - Svezia 547
CN - Cina 520
UA - Ucraina 418
SG - Singapore 234
GB - Regno Unito 143
FR - Francia 138
IT - Italia 132
IE - Irlanda 123
FI - Finlandia 85
RU - Federazione Russa 81
ID - Indonesia 78
IN - India 66
TR - Turchia 59
BE - Belgio 22
JP - Giappone 21
CI - Costa d'Avorio 18
CZ - Repubblica Ceca 18
NL - Olanda 12
CA - Canada 11
VN - Vietnam 9
IR - Iran 8
HK - Hong Kong 7
EU - Europa 6
LT - Lituania 6
AU - Australia 4
ES - Italia 4
EG - Egitto 3
PL - Polonia 3
RO - Romania 3
AR - Argentina 2
BZ - Belize 2
CH - Svizzera 2
EC - Ecuador 2
LK - Sri Lanka 2
MK - Macedonia 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
BG - Bulgaria 1
CL - Cile 1
GR - Grecia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 7.645
Città #
Chandler 565
Jacksonville 222
Ashburn 199
Singapore 180
San Mateo 173
Nanjing 142
Nürnberg 136
Dublin 122
Dearborn 105
Wilmington 85
Ann Arbor 82
Jakarta 78
Woodbridge 76
Nanchang 64
Boston 60
Izmir 58
Bremen 54
Lawrence 53
Houston 48
Moscow 46
Fairfield 43
Marseille 43
New York 43
Munich 39
Leawood 37
Redwood City 33
Fremont 31
Milan 31
Seattle 31
Kunming 28
University Park 28
Jiaxing 27
Beijing 25
Shenyang 25
Brussels 22
Hebei 21
Princeton 21
Abidjan 18
Norwalk 18
Lancaster 17
Auburn Hills 16
Changsha 16
Detroit 15
Los Angeles 15
Mountain View 15
Tianjin 15
Hangzhou 14
Helsinki 13
Redmond 12
Zhengzhou 12
Cambridge 11
Rome 11
Boardman 10
Shanghai 10
Cattolica 9
Guangzhou 8
Hanoi 8
Hefei 8
Las Vegas 8
Changchun 7
Chicago 7
Lanzhou 7
Ningbo 7
Simi Valley 7
Augusta 6
Falls Church 6
Hong Kong 6
Indiana 6
San Jose 6
Berlin 5
Jinan 5
Landshut 5
London 5
Pune 5
San Diego 5
Albuquerque 4
Amsterdam 4
Costa Mesa 4
Edinburgh 4
Mumbai 4
Toronto 4
Ardabil 3
Brno 3
Busto Arsizio 3
Chengdu 3
Dresden 3
Frankfurt am Main 3
Ottawa 3
Sacramento 3
San Francisco 3
Shenzhen 3
Tokyo 3
Washington 3
Arezzo 2
Asyut 2
Bari 2
Belize City 2
Capannori 2
Colombo 2
Dueville 2
Totale 3.524
Nome #
Neoadjuvant Concurrent Radiochemotherapy in Locally Advanced (IIIa-IIIb) Non-Small Cell Lung Cancer: long term results according to downstaging. 243
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 168
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 166
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 160
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 149
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 143
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. 141
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 139
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 138
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 138
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 133
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 131
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 131
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 130
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 130
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 129
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 129
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 128
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 128
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 122
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 121
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 121
Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine. 119
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 119
Phase I trial of weekly gemcitabin and concurrent radiotherapy in patients with inoperable non small cell lung cancer. 117
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 117
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 116
Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study 113
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 113
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 111
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 111
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 110
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 104
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 104
Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma 103
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 101
Chemoradiation therapy and IORT in locally advanced rectal cancer: preliminary results in 36 patients 100
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 100
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study. 97
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 97
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 97
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 97
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 96
Virtual simulation:fifteen years later 95
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 94
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 94
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 94
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 93
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 90
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 89
Recurrent uterine cancer after surgery: magnetic resonance imaging patterns and their changes after concomitant chemoradiation 87
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 87
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 86
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 86
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 83
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 82
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 78
Intraoperative radiation therapy in integrated treatment of rectal cancers. Results of phase II study 77
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 74
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 69
Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study 69
Whole liver intraoperative irradiation after partial hepatectomy produces minimal functional and pathologic lesions 67
The role of computed tomography in defining the target volume for the integrated therapy of orbital epitheliomas 66
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 65
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 62
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 61
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 59
Postoperative intensity-modulated radiotherapy in low-risk endometrial cancers: final results of a phase i study. 57
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 56
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) 52
Locoregional pain treatment. Troubles and prospectives: antalgic radiotherapy 51
Preoperative chemoradiation and intra-operative radiotherapy for pancreatic carcinoma 49
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). 47
INTERMITTENT INTRATHECAL METHOTREXATE AND FRACTIONAL RADIATION (M-IMFRA) PLUS CHEMOTHERAPY IN CHILDHOOD LEUKEMIA 44
Scientific committee. multidisciplinary rectal cancer management: 2nd european rectal cancer consensus conference (eureca-cc2). 41
High-dose radiotherapy plus prolonged hormone therapy in CT2-3 prostatic carcinoma: is it useful? 12
Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness. 12
The prognostic effect of clinical staging in pancreatic adenocarcinoma 10
Totale 7.698
Categoria #
all - tutte 27.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020553 0 0 0 0 0 0 153 47 69 63 131 90
2020/2021750 16 81 13 84 115 32 105 18 94 42 124 26
2021/2022820 73 91 10 69 77 19 13 120 31 39 122 156
2022/20231.501 206 210 112 248 95 185 75 123 159 15 51 22
2023/2024578 28 171 13 41 14 57 25 52 5 15 100 57
2024/2025415 45 36 96 42 164 30 2 0 0 0 0 0
Totale 7.698